Loading clinical trials...
Loading clinical trials...
This study will evaluate the efficacy, safety, and tolerability of VX-880 in participants with Type 1 Diabetes (TID) with a kidney transplant.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Vertex Pharmaceuticals Incorporated
NCT05753930 · Kidney Transplantation in Highly Sensitized Patients
NCT07224321 · Type 1 Diabetes Mellitus
NCT07395050 · Stage 3 Type 1 Diabetes
NCT07457580 · Type 1 Diabetes
NCT06059664 · Kidney Transplant; Complications
Perelman Center for Advanced Medicine - Endocrinology
Philadelphia, Pennsylvania
Montefiore Clinical and Translational Research Center - Endocrinology
Pittsburgh, Pennsylvania
UW University Hospital - Endocrinology
Madison, Wisconsin
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions